Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

2008 2007

Revenues:

Product sales $101,507 $87,152

Collaborative research revenue 2,459 2,352

Royalty and license revenue 18,597 11,547

Total revenues 122,563 101,051

Operating expenses:

Cost of product sales 32,636 29,160

Research and development 23,066 20,258

Marketing and sales 11,908 9,536

General and administrative 11,937 11,281

Total operating expenses 79,547 70,235

Income from operations 43,016 30,816

Interest income 4,207 2,675

Other income/(expense) 1,473 (130)

Total other income, net 5,680 2,545

Income before income tax 48,696 33,361

Income tax expense 16,751 11,886

Net income $31,945 $21,475

Net income per share:

Basic $0.59 $0.41

Diluted $0.58 $0.40

Weighted average shares outstanding:

Basic 53,796 52,170

Diluted 55,023 53,634

Gen-Probe Incorporated

Consolidated Statements of Cash Flows

(In thousands)


'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email: